BPC-157/KPV/GHK-Cu Capsules Price Comparison — Prices & Recorded COA Details
Compare BPC-157/KPV/GHK-Cu capsule prices, capsule count, mg per capsule, cost per capsule, and recorded COA metadata. Inspect actual batch reports independently.
Compare BPC-157/KPV/GHK-Cu Capsules purchase prices, nominal quantities, discount codes and recorded COA fields. Availability flags, purity values and dates are metadata, not independent verification; inspect the actual batch report.
About BPC-157/KPV/GHK-Cu Blend
Compound context: Pre-clinical / research-onlyBPC-157/KPV/GHK-Cu Blend is compared here in capsule format. Capsule count, strength per capsule, and total milligrams per bottle describe the listed product; they do not establish a dosing protocol.
What to check before you buy BPC-157/KPV/GHK-Cu Blend:
- Confirm capsule count and milligrams per capsule on the finished product label.
- Check that the actual report identifies the finished capsule product and matches its batch and strength.
- Compare bottle price separately from price per capsule and price per milligram. Missing quantities cannot support normalized comparisons.
Research context — not capsule instructions or evidence of equivalent dosing: No regulatory approvals for the blend or for any of its three components. Each individual component is described in its standalone entry in this catalogue. **Typical dose:** No validated human dose for the blend. Vendor-typical compounded ratios pair BPC-157 250–500 µg, KPV 250–500 µg, and GHK-Cu 1–2 mg per dose, given subcutaneously, but these are commercial conventions and not the output of any registered dose-finding study.
Regulatory: Compound-level context, not approval of the capsule listings: Compounded research-peptide blend. No published human trial of the combination; each individual component has its own (limited) pre-clinical literature.
BPC-157/KPV/GHK-Cu Blend: Mechanisms, Half-Life & Research Data
Compound research context for BPC-157/KPV/GHK-Cu Blend, not capsule dosing guidance. Studies of other formulations do not establish equivalence to these listings. All citations resolve to the sources list at the bottom of this page.
How it works
Research on the compound and other formulations does not establish the properties or dose of the capsules listed here. The BPC-157 / KPV / GHK-Cu blend is a commercial compounding convention rather than a clinical-stage therapeutic entity. The rationale offered by vendors is that the three peptides cover complementary tissue-repair mechanisms — BPC-157 for tendon, ligament and gut,[1][2] KPV for mucosal anti-inflammation,[3][5] GHK-Cu for dermal collagen synthesis and copper-dependent wound repair[4] — and that pairing them in a single subcutaneous injection is more convenient than separate vials. **There is no published preclinical or clinical pharmacokinetic, safety, or efficacy study of the three-peptide combination as administered together; the supporting evidence base is entirely the sum of the three independent component literatures, each of which is summarised in its own standalone entry in this catalogue.** Refer to the BPC-157, KPV, and GHK-Cu standalone entries for full mechanistic detail. The most defensible mechanistic statement about the blend specifically is that the three peptides act through unrelated molecular pathways (NO/VEGFR2/pentadecapeptide effects,[1][2] melanocortin-related anti-inflammation,[3][5] copper-binding wound-healing modulation[4]), so the combined pharmacology is not expected to differ in kind from administering each separately at the same dose. **No drug-drug interaction studies have been done, and there is no reason to assume any of the three components will reach a different free-fraction or tissue distribution when co-administered.**
Active research areas
- Research status & evidence base**Human evidence for the blend: none.** No published clinical trial. **Pre-clinical evidence for the blend: none.** **Pre-clinical evidence for each individual component:** summarised in the BPC-157, KPV, and GHK-Cu standalone entries — most extensive for BPC-157 in rodent gut and tendon repair, moderate for GHK-Cu in dermal wound healing (including some small human cosmetic-formulation trials), and moderate for KPV in rodent colitis models. **No FDA-registered manufacturer makes any of the three components for parenteral human use, and the blend is not the subject of any registered clinical trial.**
Sources & references (5)
Peer-reviewed literature, FDA documents, and trial registrations cited above. Vendor pricing, COA data, and live calculator statistics shown elsewhere on this page are sourced from the WPA database independently of this list.
- [1]Sikiric P et al., Curr Pharm Des 2010 — Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. · PMID: 20388117 link
- [2]Sikiric P et al., Curr Med Chem 2018 — Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease. · PMID: 29278200 link
- [3]Kannengiesser K et al., Inflamm Bowel Dis 2008 — Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. · PMID: 18044795 link
- [4]Pickart L, Margolina A. Biomed Res Int 2015 — Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. · PMID: 26236730 link
- [5]Brzoska T et al., Ann N Y Acad Sci 2003 — α-Melanocyte-stimulating hormone and related tripeptides: biochemistry, anti-inflammatory and protective effects in vitro and in vivo. · PMID: 12865188 link
What BPC-157/KPV/GHK-Cu Capsules Costs Right Now
WPA currently tracks BPC-157/KPV/GHK-Cu Capsules from 1 distinct vendor. The cheapest in-stock BPC-157/KPV/GHK-Cu Capsules listing is $116.99. Modified Aminos holds the lowest sticker price at $116.99. Normalized to milligrams, BPC-157/KPV/GHK-Cu Capsules costs $0.975/mg on this page. The best per-milligram value is the listed 120 mg purchase quantity from Modified Aminos.
BPC-157/KPV/GHK-Cu Capsules is stocked in a single size: 120 mg per package. Because bottles of different strengths rarely scale linearly in price, the per-milligram column is the only fair way to rank them.
BPC-157/KPV/GHK-Cu Capsules Discount Codes
1 of the 1 tracked BPC-157/KPV/GHK-Cu Capsules listing carries a WPA researcher discount code. The largest live discount is 10% off. Every price and per-milligram figure on this page is the post-discount number, so you are never comparing a discounted listing against an undiscounted one. Codes change and some exclude sale items or carry order minimums.
About BPC-157/KPV/GHK-Cu
BPC-157/KPV/GHK-Cu Blend is compared here in capsule format. Capsule count, strength per capsule, and total milligrams per bottle describe the listed product; they do not establish a dosing protocol.
BPC-157/KPV/GHK-Cu is a blend of BPC-157, GHK-Cu, and KPV, so a COA has to confirm each component separately — a single purity figure for the mixture is not enough. Compound-level context, not approval of the capsule listings: Compounded research-peptide blend.
How to Read the BPC-157/KPV/GHK-Cu Capsules Comparison
- Price per milligram — Every BPC-157/KPV/GHK-Cu Capsules listing is normalized to $0.975/mg-style unit pricing, so a small cheap bottle cannot hide a worse real cost than a larger one.
- Stock status — Live in-stock state for each BPC-157/KPV/GHK-Cu Capsules listing, refreshed on a recurring basis.
Reading BPC-157/KPV/GHK-Cu Capsule Listings
Capsule listings are ranked on total BPC-157/KPV/GHK-Cu per bottle — capsule count multiplied by milligrams per capsule — rather than on bottle price, because a cheaper bottle with fewer or weaker capsules routinely costs more per milligram. A capsule COA should test the finished capsule rather than the raw powder, and it should cover the exact capsule strength on sale.
Oral capsule formats differ from injectable vials in route of administration and bioavailability, so a BPC-157/KPV/GHK-Cu protocol written for one format does not transfer to the other. Confirm the vendor's COA covers the capsule product specifically.
Frequently Asked Questions: BPC-157/KPV/GHK-Cu Capsules
How are BPC-157/KPV/GHK-Cu capsule prices compared?
Bottle price, capsule count, and milligrams per capsule are separate listing fields. Total milligrams per bottle equals capsule count × milligrams per capsule; price per milligram divides the bottle price by that total. Price per capsule divides the bottle price by the capsule count. A missing quantity leaves the corresponding normalized price unavailable.
Are BPC-157/KPV/GHK-Cu capsules supplied as powder for reconstitution?
These listings are capsules, not vials for reconstitution. Check the finished capsule label, capsule count, strength, and matching batch report. Vial preparation instructions do not apply to capsule listings.
Can calculator entries establish a BPC-157/KPV/GHK-Cu capsule protocol?
No. WPA calculator entries are compound-wide inputs, not confirmed administration or capsule-specific usage. They do not establish a capsule dose, schedule, bottle duration, or monthly protocol cost. This page compares catalog prices without seeding a capsule monthly planner.
Can BPC-157/KPV/GHK-Cu capsule and injectable doses be converted?
No route-equivalent dose can be inferred from these listings. Absorption depends on the compound and formulation; a generic absorption percentage or multiplier cannot establish capsule dosing. Cited studies of other formulations are research context, not instructions for the capsules offered here.